Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Anatomy of the Circulatory System02:03

Anatomy of the Circulatory System

The human circulatory system consists of blood, blood vessels that carry blood away from the heart, around the body, and back to the heart, and the heart itself, which acts as a central pump. The systemic circuit supplies blood to the whole body, the coronary circuit supplies blood to the heart, and the pulmonary circuit supplies blood flow between the heart and lungs.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.

European journal of preventive cardiology·2025
Same author

The Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.

European heart journal. Acute cardiovascular care·2025
Same author

The Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.

European heart journal·2025
Same author

The Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.

Journal of the American College of Cardiology·2025
Same author

Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.

Circulation·2025
Same author

The Role of Cardiovascular Disease Journals in Reporting Sex and Gender in Research.

JAMA cardiology·2025

Related Experiment Video

Updated: May 26, 2026

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
09:43

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic

Virginia M Miller1, Jay R Kaplan, Nicholas J Schork

  • 1Departments of Surgery, Physiology and Biomedical Engineering, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. miller.virginia@mayo.edu.

Biology of Sex Differences
|December 14, 2011
PubMed
Summary
This summary is machine-generated.

Understanding sex differences in cardiovascular disease is crucial. This study outlines methods for designing animal and cell-based research to explore these sex-based variations in cardiovascular health and treatment responses.

More Related Videos

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter
07:53

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter

Published on: June 16, 2022

Related Experiment Videos

Last Updated: May 26, 2026

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging
09:43

Multimodal Study of Murine Cardiovascular Remodeling: Four-Dimensional Ultrasound and Mass Spectrometry Imaging

Published on: January 10, 2025

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways
10:44

Sex Stratified Neuronal Cultures to Study Ischemic Cell Death Pathways

Published on: December 9, 2013

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter
07:53

Standardized Rat Coronary Ring Preparation and Real-Time Recording of Dynamic Tension Changes Along Vessel Diameter

Published on: June 16, 2022

Area of Science:

  • Cardiovascular research
  • Sex differences in disease
  • Translational medicine

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death, with higher mortality in women in the US.
  • While psychosocial factors are known, the physiological and molecular bases for sex differences in CVD development and treatment response are understudied.
  • Existing research often overlooks critical biological sex differences.

Purpose of the Study:

  • To provide guidance on designing animal and tissue/cell-based studies.
  • To address the need for research on sex-based physiological and molecular differences in cardiovascular disease.
  • To improve the understanding of sex differences in cardiovascular structure, function, and disease models.

Main Methods:

  • Incorporating appropriate experimental material including species/strain characteristics, sex, and hormonal status.
  • Considering the reproductive status and history of animals, including gonadal steroid presence.
  • Selecting experimental animals based on diet, lifespan, estrous cycle frequency, and disease modulation capabilities.
  • Accounting for environmental factors like sleep/wake cycles, social interaction, and handling that influence hormones.
  • Carefully selecting hormonal treatments and routes of administration.

Main Results:

  • Study designs must account for sex and hormonal status to identify sex differences.
  • Reproductive status, hormonal milieu, and environmental factors significantly influence experimental outcomes.
  • Phytoestrogen consumption, lifespan, and estrous cycle characteristics are important considerations for animal models.
  • Stress and social factors can interact with sex steroid hormone pathways, impacting results.
  • Hormonal treatment selection and administration route are critical variables.

Conclusions:

  • Accounting for sex in study design and interpretation is essential for advancing cardiovascular disease knowledge.
  • This approach is vital for developing effective translational strategies for human cardiovascular health.
  • Integrating sex as a biological variable enhances the foundation for preventing, diagnosing, and treating cardiovascular diseases.